Cellectis (CLLS) Net Cash Flow (2015 - 2026)

Cellectis' Net Cash Flow history runs 12 years deep, the most recent figure standing at -$26.5 million for Q1 2026.

• On a quarterly basis, Net Cash Flow fell 55.49% year-over-year to -$26.5 million in Q1 2026; TTM through Mar 2026 was -$95.1 million, a 1757.56% decrease from a year earlier, with the FY2025 full-year figure at -$85.6 million, down 1021.52% from the prior year.
• Net Cash Flow retreated to -$26.5 million in Q1 2026 per CLLS's latest filing, from $8.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $64.0 million in Q4 2023 and bottomed at -$67.3 million in Q2 2025.
• The 5-year median for Net Cash Flow is -$13.5 million (2024), against an average of -$7.8 million.
• Across the five-year window, Net Cash Flow soared 4143.5% in 2024 and slumped 377.39% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $5.4 million in 2022, then surged by 1088.71% to $64.0 million in 2023, then tumbled by 121.54% to -$13.8 million in 2024, then jumped by 157.69% to $8.0 million in 2025, then slumped by 432.98% to -$26.5 million in 2026.
• Per Business Quant, the three latest CLLS Net Cash Flow figures stand at -$26.5 million (Q1 2026), $8.0 million (Q4 2025), and -$9.3 million (Q3 2025).